Table 3.
Comparison of the complete symptom resolution rates between dexlansoprazole and esomeprazole over one week (Subgroup analysis by gender) n (%)
Time | Gender | Dexlansoprazole | Esomeprazole | P value |
CSR Day 1 | Female | 13 (27.7) | 6 (15.8) | 0.192 |
Male | 8 (23.5) | 17 (39.5) | 0.136 | |
CSR Day 3 | Female | 18 (38.3) | 7 (18.4) | 0.046 |
Male | 9 (26.5) | 19 (44.2) | 0.109 | |
CSR Day 7 | Female | 26 (55.3) | 14 (36.8) | 0.090 |
Male | 16 (47.1) | 25 (58.1) | 0.333 |
CSR: Complete symptom resolution.